NYSE Content Advisory: Pre-Market update + Bank of America beats earnings estimates

4/15/25 8:55:00 AM ET

$AXS

$BAC

$CAT

Property-Casualty Insurers

Finance

Major Banks

Finance

Get the next $AXS alert in real time by email

NEW YORK, April 15, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.

Kristen Scholer delivers the pre-market update on April 15th

Bank of America (NYSE: BAC) reported better than expected results this morning, raising share price pre-market.
General Motors (NYSE:GM) and Ford (NYSE:F) rose after President Trump's comments around helping auto companies
Johnson & Johnson (NYSE: JNJ), Citigroup (NYSE:C), and PNC (NYSE:PNC) highlight upcoming earnings

Opening Bell

Caterpillar (NYSE:CAT) celebrates its 100^th anniversary

Closing Bell

Axis Capital (NYSE: AXS) marks the two-year anniversary of Vincent Tizzio as President & CEO

Download the NYSE TV App and Subscribe Here

View original content to download multimedia:https://www.prnewswire.com/news-releases/nyse-content-advisory-pre-market-update--bank-of-america-beats-earnings-estimates-302428948.html

SOURCE New York Stock Exchange

Get the next $AXS alert in real time by email

Recent Analyst Ratings for

$AXS

$BAC

$CAT

Company	Date	Price Target	Rating	Analyst
Caterpillar Inc. $CAT	8/19/2025	$476.00	In-line → Outperform	Evercore ISI
Caterpillar Inc. $CAT	8/7/2025	$350.00	Equal-Weight → Underweight	Morgan Stanley
PNC Financial Services Group Inc. $PNC	7/30/2025	$238.00	Perform → Outperform	Oppenheimer
Johnson & Johnson $JNJ	7/23/2025		Hold → Buy	Erste Group
General Motors Company $GM	7/21/2025	$65.00	Buy	The Benchmark Company
PNC Financial Services Group Inc. $PNC	7/9/2025	$212.00	Underperform → Mkt Perform	Keefe Bruyette
Caterpillar Inc. $CAT	7/9/2025	$500.00	Hold → Buy	Melius
Bank of America Corporation $BAC	7/8/2025	$51.00	Buy → Hold	HSBC Securities

More analyst ratings

Recent Analyst Ratings for

$AXS

$BAC

$CAT

Company	Date	Price Target	Rating	Analyst
Caterpillar Inc. $CAT	8/19/2025	$476.00	In-line → Outperform	Evercore ISI
Caterpillar Inc. $CAT	8/7/2025	$350.00	Equal-Weight → Underweight	Morgan Stanley
PNC Financial Services Group Inc. $PNC	7/30/2025	$238.00	Perform → Outperform	Oppenheimer
Johnson & Johnson $JNJ	7/23/2025		Hold → Buy	Erste Group
General Motors Company $GM	7/21/2025	$65.00	Buy	The Benchmark Company
PNC Financial Services Group Inc. $PNC	7/9/2025	$212.00	Underperform → Mkt Perform	Keefe Bruyette
Caterpillar Inc. $CAT	7/9/2025	$500.00	Hold → Buy	Melius
Bank of America Corporation $BAC	7/8/2025	$51.00	Buy → Hold	HSBC Securities

More analyst ratings

NYSE Content Advisory: Pre-Market update + Bank of America beats earnings estimates

Crush Q3 2025 with the Best AI Superconnector

Recent Analyst Ratings for $AXS$BAC$C$CAT

NYSE Content Advisory: Pre-Market update + Bank of America beats earnings estimates

Crush Q3 2025 with the Best AI Superconnector

Recent Analyst Ratings for $AXS$BAC$C$CAT

$AXS$BAC$C$CAT Analyst Ratings

Caterpillar upgraded by Evercore ISI with a new price target

Caterpillar downgraded by Morgan Stanley with a new price target

PNC upgraded by Oppenheimer with a new price target

$AXS$BAC$C$CAT FDA approvals

July 21, 2023 - FDA Roundup: July 21, 2023

May 5, 2022 - Coronavirus (COVID-19) Update: FDA Limits Use of Janssen COVID-19 Vaccine to Certain Individuals

August 18, 2021 - Joint Statement from HHS Public Health and Medical Experts on COVID-19 Booster Shots

$AXS$BAC$C$CAT Insider Purchases

President Wiedman Mark bought $3,568 worth of $5 Par Common Stock (20 units at $178.40) (SEC Form 4)

Director Maclennan David bought $120,262 worth of shares (375 units at $320.70), increasing direct ownership by 6% to 6,653 units (SEC Form 4)

Director Johnson Gerald bought $31,848 worth of shares (100 units at $318.48), increasing direct ownership by 3% to 3,165 units (SEC Form 4)

$AXS$BAC$C$CAT SEC Filings

SEC Form 144 filed by Johnson & Johnson

SEC Form FWP filed by Bank of America Corporation

SEC Form FWP filed by Citigroup Inc.

$AXS$BAC$C$CAT Insider Trading

Executive Chairman Umpleby Iii Donald J sold $7,088,152 worth of shares (17,168 units at $412.87), decreasing direct ownership by 3% to 482,505 units (SEC Form 4)

Executive VP, General Counsel Forminard Elizabeth exercised 11,521 shares at a strike of $115.67 and covered exercise/tax liability with 9,570 shares, increasing direct ownership by 18% to 12,853 units (SEC Form 4)

Chair & CEO Barra Mary T sold $57,931,159 worth of shares (994,863 units at $58.23) and exercised 607,024 shares at a strike of $36.85, decreasing direct ownership by 35% to 552,238 units (SEC Form 4)

$AXS$BAC$C$CAT Press Releases

Merrill and Bank of America Private Bank Launch New Alternative Investments Program to Ultra-High-Net-Worth Clients

Citi to Deliver New Customized Portfolio Offering Powered by BlackRock to Citi Wealth Clients Globally

NYSE Content Advisory: Pre-Market Update + Biotech Enveda raises $150 million to reach unicorn status

$AXS$BAC$C$CAT Leadership Updates

Citi to Deliver New Customized Portfolio Offering Powered by BlackRock to Citi Wealth Clients Globally

NYSE Content Advisory: Pre-Market update + Fed Chair Jerome Powell Set to Deliver Jackson Hole Speech

Alaska Airlines and Bank of America present a new premium credit card designed for global travelers, the Atmos™ Rewards Summit Visa Infinite® card

$AXS$BAC$C$CAT Financials

Merrill and Bank of America Private Bank Launch New Alternative Investments Program to Ultra-High-Net-Worth Clients

Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results

The PNC Financial Services Group Announces Third Quarter Conference Call Details

$AXS$BAC$C$CAT Large Ownership Changes

Amendment: SEC Form SC 13D/A filed by Bank of America Corporation

Amendment: SEC Form SC 13G/A filed by PNC Financial Services Group Inc.

Amendment: SEC Form SC 13G/A filed by PNC Financial Services Group Inc.

Recent Analyst Ratings for
$AXS
$BAC
$C
$CAT

Recent Analyst Ratings for
$AXS
$BAC
$C
$CAT

$AXS
$BAC
$C
$CAT
Analyst Ratings

$AXS
$BAC
$C
$CAT
FDA approvals

$AXS
$BAC
$C
$CAT
Insider Purchases

$AXS
$BAC
$C
$CAT
SEC Filings

$AXS
$BAC
$C
$CAT
Insider Trading

$AXS
$BAC
$C
$CAT
Press Releases

$AXS
$BAC
$C
$CAT
Leadership Updates

$AXS
$BAC
$C
$CAT
Financials

$AXS
$BAC
$C
$CAT
Large Ownership Changes